Fintel reports that on September 24, 2025, JMP Securities initiated coverage of Assembly Biosciences (NasdaqGS:ASMB) with a Market Outperform recommendation. Analyst Price Forecast Suggests 51.99% ...
Investing.com - Assembly Biosciences (NASDAQ:ASMB), which has surged over 130% in the past six months and is trading near its 52-week high of $27.17, received a Market Outperform rating initiation ...